We all remember the emergence of COVID-19 during the first quarter of 2020. As the virus spread and infection rates spiked enrollment within most clinical …
Today, several biopharmaceutical firms are taking their therapies to the clinical study phase, so the stakes are high. Many of these evolving firms have spent …